Last reviewed: June 4, 2026
Last updated: June 4, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Wegovy contains semaglutide, a GLP-1 receptor agonist, while tirzepatide activates both GLP-1 and GIP receptors as a dual-action peptide. These medications work through different biological pathways, leading to distinct clinical outcomes and side effect profiles that matter when selecting your personalized weight loss treatment.
What Is Wegovy and How Does It Work?
Wegovy is a brand-name semaglutide injection developed by Novo Nordisk for chronic weight management in adults with obesity or overweight with weight-related conditions. Semaglutide mimics glucagon-like peptide-1, a naturally occurring hormone that regulates appetite and blood sugar levels. The medication signals your brain's satiety centers, reducing hunger and increasing feelings of fullness after smaller meals.
Clinical trials show Wegovy achieves average weight loss of 15-22% of body weight over 68 weeks in people who maintain lifestyle changes. The medication requires weekly injections and follows a structured dose escalation protocol starting at 0.25 mg, increasing every 4 weeks until reaching a therapeutic maintenance dose. Common side effects include nausea, vomiting, and gastrointestinal symptoms that often improve as your body adapts.
What Makes Tirzepatide Different From Semaglutide?
Tirzepatide activates two receptor pathways instead of one: GLP-1 and GIP (glucose-dependent insulinotropic polypeptide). This dual-action mechanism addresses appetite regulation through multiple biological routes simultaneously, potentially explaining why tirzepatide produces greater weight loss in head-to-head comparisons. Studies published in major medical journals demonstrate tirzepatide reduces body weight by 21-22% at standard doses, with some patients achieving reductions exceeding 25%.
The GIP component of tirzepatide activates receptors in your gut and brain that enhance insulin secretion and improve metabolic flexibility. This additional pathway may provide metabolic advantages beyond what GLP-1 activation alone delivers, particularly for individuals with insulin resistance or metabolic syndrome. Tirzepatide also uses a weekly injection format but with a different dose escalation schedule compared to semaglutide.
Comparing Clinical Efficacy: Trial Data and Real-World Results
The SURMOUNT-1 trial directly compared tirzepatide 15 mg to semaglutide 2.4 mg (Wegovy's highest approved dose) in 2,539 adults over 72 weeks. Participants receiving tirzepatide experienced average weight loss of 22.5% compared to 16% in the semaglutide group—a clinically meaningful 6.5 percentage point difference favoring the dual-action approach. Blood sugar improvements and cardiovascular risk factor reductions also favored tirzepatide across multiple measures.
Real-world outcomes from compounding pharmacies using tirzepatide show similar patterns, with many patients reporting progressive weight loss through 6 months of treatment and sustained results at 12 months. Individual response varies based on genetics, adherence, lifestyle modifications, and whether your specific peptide pathways align optimally with tirzepatide's mechanism. PlexusDx's Precision Peptide Genetic Test maps 14 metabolic pathways to identify which patients show the strongest predicted response to tirzepatide versus other GLP-1 compounds.
Cost Comparison and Access: Wegovy vs. PlexusDx Tirzepatide
Wegovy's retail price ranges from $900 to $1,350 per month depending on dosing and pharmacy, requiring insurance coverage or direct out-of-pocket payment with limited copay assistance programs. Most insurance plans now cover Wegovy, but formulary restrictions, prior authorization requirements, and step-therapy protocols delay access for many patients. PlexusDx's compounded tirzepatide injection starts at $249 per month—a fraction of brand-name costs—with flat pricing across all commitment tiers, meaning your dose can increase without price increases.
PlexusDx compounded tirzepatide comes from licensed 503A compounding pharmacies serving all 50 states without membership fees or insurance requirements. The service is HSA/FSA eligible, providing additional savings for qualified accounts. Adding the Precision Peptide Genetic Test ($99 after your first month) identifies your genetic predispositions across 49 peptides and 150+ metabolic insights, enabling true precision therapy rather than trial-and-error dosing.
Which Medication Is Right for Your Weight Loss Goals?
Choosing between tirzepatide and semaglutide depends on your individual factors: baseline weight, metabolic health status, genetic peptide sensitivity, budget, and tolerance for medication side effects. Tirzepatide's dual-pathway activation typically produces faster and more substantial weight loss, making it ideal for patients with significant obesity or those who haven't achieved adequate results with GLP-1-only therapy. Semaglutide may be preferable for individuals seeking a lower-cost option or those with contraindications to GIP pathway activation.
PlexusDx offers both compounded semaglutide and tirzepatide, plus combination protocols like GLP-Squared (dual compound) for patients requiring enhanced metabolic support. Your PlexusDx provider reviews your medical history, current medications, and genetic testing results to recommend the medication most aligned with your physiology. If your initial choice doesn't produce expected results within 8-12 weeks, switching between compounds is straightforward without expensive new prescriptions or authorization delays.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Does Wegovy contain tirzepatide?
No. Wegovy contains semaglutide, a GLP-1 receptor agonist. Tirzepatide is a separate medication that activates both GLP-1 and GIP receptors, creating a dual-action mechanism distinct from Wegovy's single-pathway approach.
Which medication causes more weight loss: semaglutide or tirzepatide?
Clinical trials show tirzepatide produces approximately 6-7% greater weight loss than semaglutide at comparable doses. The SURMOUNT-1 trial demonstrated 22.5% weight reduction with tirzepatide versus 16% with semaglutide (2.4 mg) over 72 weeks in people with obesity.
How much does PlexusDx tirzepatide cost compared to Wegovy?
PlexusDx compounded tirzepatide injection starts at $249 per month with flat pricing across all tiers, while Wegovy typically costs $900-$1,350 monthly. PlexusDx requires no insurance, no membership fee, and pricing never increases with dose escalation.
Are compounded tirzepatide and semaglutide as safe as brand-name medications?
PlexusDx's compounded medications come from licensed 503A compounding pharmacies operating under FDA oversight and state pharmacy board regulations. While compounded medications are not FDA-approved, 503A compounds meet pharmaceutical standards for sterility, potency, and quality.
How does the Precision Peptide Genetic Test help choose between tirzepatide and semaglutide?
PlexusDx's Precision Peptide Genetic Test analyzes variants in GLP1R (rs6923761), GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) pathways plus 45 additional peptides across 14 metabolic systems.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
What Are the Different Types of GLP-1 Drugs?
Fueling Your Morning: What to Eat for Breakfast While on Ozempic for a Healthier You